#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Marfan's syndrome Liver transplant rejection Anal cancer recurrent Ewing's sarcoma Cystic fibrosis respiratory infection suppression Spinal cord injury cervical Alport's syndrome Indolent systemic mastocytosis Astrocytoma Dermatitis Laryngeal squamous cell carcinoma Immune-mediated myasthenia gravis Acquired ATTR amyloidosis Phenylketonuria Interstitial lung disease More trials…

    Learn about Rare Diseases

    Hereditary angioedema – Trials in Disease Progressive multifocal leukoencephalopathy – Diagnostics Krabbe’s disease – Trials in Disease Indolent systemic mastocytosis – Trials in Disease Ewing’s sarcoma recurrent Methylmalonic acidaemia – Life with Disease Pelizaeus-Merzbacher disease Congenital hypotransferrinaemia – Basic Information Haemophilia A with anti factor VIII Testicular leiomyosarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Metoprolol Tartrate Carbidopa Balstilimab LUTETIUM LU-177 Namodenoson INF904 Atidarsagene Autotemcel Soya-Bean Oil Refined ZILUCOPLAN Human Coagulation Factor Ix GS-4321 Esomeprazole Magnesium Celecoxib Paracetamol Vorasidenib Omx-0407 Arginine Hydrochloride Melphalan Flufenamide Sotrovimab Sumatriptan Succinate More therapies…

    Learn about Your Condition

    MELAS syndrome Systemic mastocytosis Anal squamous cell carcinoma Seizure Myotonia Malignant melanoma stage III Onychomycosis ROHHAD syndrome Metastatic neoplasm Myocarditis Cholangitis sclerosing Haematological infection Choroidal neovascularisation Injection site pain Meniscus operation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Indolent systemic mastocytosis

  • Study of Elenestinib for Patients with Indolent Systemic Mastocytosis

    Recruiting

    4 1
    Investigated Diseases:
    • Indolent systemic mastocytosis
    Investigated Drugs:
    • Elenestinib Phosphate
    Austria Belgium Czechia Denmark France Germany +9

  • Study of TL-895 for Patients with Relapsed or Refractory Myelofibrosis or Indolent Systemic Mastocytosis

    Recruiting

    2 1
    Investigated Diseases:
    • Indolent systemic mastocytosis
    Investigated Drugs:
    • 1-4-{[6-Amino-5-(4-Phenoxy-Phenyl)-Pyrimidin-4-Ylamino]-Methyl}-4-Fluoro-Piperidin-1-Yl)-Propenone
    Belgium Bulgaria France Germany Italy The Netherlands +3

  • Study of Avapritinib for Patients with Indolent Systemic Mastocytosis Not Adequately Managed by Standard Therapy

    Not recruiting

    2 1
    Investigated Drugs:
    • Avapritinib
    Belgium Denmark France Germany Italy The Netherlands +3

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!